The prescription is the easy part. The monitoring is the medicine.
Starting testosterone therapy is a single decision. Keeping it working — and keeping it safe — is an ongoing one, made at every follow-up against fresh bloodwork. This is how monitoring works at Castellano Health Institute: the 8-week recheck, the lab cadence after that, the markers that get tracked, and why continuous management matters more than the first script.
Castellano Health Institute · Serving Orange County
From first dose to steady state.
- Week 0
Start of therapy
Once the diagnosis is confirmed and a protocol is chosen, therapy begins from a known baseline — the labs from your workup are the reference every future check is read against.
- Week 8
First recheck
Bloodwork is redrawn — total testosterone, estradiol, hematocrit, PSA where age-appropriate. Levels have stabilized enough to judge the dose. Dr. Castellano fine-tunes the dose or delivery method if the picture calls for it.
- Monthly
Follow-up visits
A monthly touchpoint — in-office or telehealth — to check how you're feeling against the numbers, manage anything that comes up, and keep the plan matched to real life.
- Ongoing
Quarterly monitoring
After the early adjustments settle, labs move to a steady rhythm, typically quarterly, tracking the safety and effect markers against your own baseline over time.
Read too early and you’re chasing a moving target.
The first recheck is set at 8 weeks for a reason. That’s roughly the point where levels have stabilized enough to judge whether the dose is right. Draw labs before that and you’re reading a system still settling in — the numbers don’t yet reflect where therapy is actually landing. The 8-week recheck is where the picture has stabilized enough to act on.
At that visit, bloodwork gets redrawn and Dr. Castellano walks through the numbers with you: how you’re feeling measured against where your levels actually are, and whether the dose or the delivery method should change. Different symptoms respond on different timelines — drive and mood tend to shift within weeks, while strength and body-composition changes build over months — so the recheck reads the labs and the lived experience side by side. After the early adjustments settle, the cadence drops to a steady quarterly rhythm.
The markers that matter for effect and safety.
Ongoing monitoring isn’t a single number — it’s a small set of markers read together:
- Total testosterone — to confirm you’re in a healthy physiologic range, not above it.
- Estradiol — testosterone converts to estrogen, and the balance is worth watching.
- Hematocrit (via the complete blood count) — the red-cell concentration testosterone can push too high over months.
- PSA — tracked where age calls for it, as a standard part of prostate safety.
Over the longer run, lipids are watched too, as part of keeping an eye on cardiovascular safety across months and years on therapy — another reason the monitoring keeps going rather than stopping once the dose is dialed in. The single most important marker to watch on an ongoing basis, though, is hematocrit. When it climbs too high, Dr. Castellano manages it in-office with therapeutic phlebotomy rather than pausing treatment or sending you elsewhere. What each of these markers measures, in plain terms, is broken down on the lab panel explained— and why this monitoring is what makes therapy safe is covered on is TRT safe.
Managed care means the plan actually changes when it should.
Monitoring only matters if something is done with what it finds. The whole reason to recheck bloodwork is that testosterone therapy is rarely “set it and forget it” — the right dose for you in month two may not be the right dose in month twelve, and the labs are how that gets caught. An adjustment can be as simple as a change in dose, or a change in the delivery method — in-office injection, self-administered injection, or topical — when one fits your response or your schedule better than another.
The most important adjustments come from the places where the labs and the way you feel don’t match up. A man whose numbers look fine but who still feels off, or one whose levels are climbing while a safety marker like hematocrit creeps upward, is exactly the situation continuous monitoring is built to surface. Reading the two together — the objective numbers and the lived experience — is what separates managed care from a standing prescription that never gets revisited.
It’s also why nothing here is on autopilot. The plan is meant to move with you: tightened when a marker drifts, eased when it doesn’t need to be aggressive, and always anchored to the same baseline your therapy started from.
What men ask about ongoing care.
Don’t see yours? Call the office and ask Dr. Castellano directly.
How often do you get bloodwork on TRT?
Why is the first TRT recheck at 8 weeks?
What gets measured at a TRT follow-up?
What happens if my hematocrit gets too high on TRT?
Is monitoring included in the $250/month program?
Do I have to keep getting labs, or can I just refill?
Will I see the same doctor at every follow-up?
Related in the TRT knowledge cluster.
Is TRT Safe?
Why monitoring — not luck — is what keeps testosterone therapy safe.
The TRT Lab Panel, Explained
What each tracked marker measures, in plain terms.
Your First TRT Consultation
How it all starts — the one-hour visit and the baseline labs.
TRT with Dr. Castellano
The service page — how testosterone replacement therapy is practiced here.
Numbers are only as good as who’s reading them.
Monitoring is only as valuable as the judgment behind it. Dr. Castellano is board certified by the American Board of Family Medicine (ABFM) and the American Board of Anti-Aging & Regenerative Medicine (ABAARM), with a fellowship in anti-aging and regenerative medicine — credentials built specifically around hormone health and the labs that track it. When your bloodwork comes back, it’s read by a physician trained to know what the pattern means.
Mon–Fri 9 AM – 5 PM · Serving Orange County